Lentiginous eruption in resolving psoriasis plaques during treatment with ixekizumab: a case report and review of the literature
We report the case of a 56-year old male with severe plaque psoriasis that was successfully treated with ixekizumab, a new anti interleukin (IL)-17 monoclonal antibody. During the first months of treatment he developed a lentiginous eruption in the sites of rapidly resolving plaques. Biopsy and immu...
Gardado en:
Main Authors: | Pablo Santa María (Author), Fernando Valenzuela (Author), Claudia Morales (Author), Raul De la Fuente (Author), Roberto Cullen (Author) |
---|---|
Formato: | Libro |
Publicado: |
PAGEPress Publications,
2017-10-01T00:00:00Z.
|
Subjects: | |
Acceso en liña: | Connect to this object online. |
Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|
Títulos similares
-
RETRACTED: Eruptive lentiginosis in resolving psoriatic plaques
por: Robert Micieli, BSc, et al.
Publicado: (2018) -
Emerging targeted therapies for plaque psoriasis – impact of ixekizumab
por: Kazemi T, et al.
Publicado: (2017) -
Potential role of ixekizumab in the treatment of moderate-to-severe plaque psoriasis
por: Ren V, et al.
Publicado: (2013) -
Clinical utility of ixekizumab in the treatment of moderate-to-severe plaque psoriasis
por: Sekhon S, et al.
Publicado: (2017) -
Role of IL-17 in plaque psoriasis: therapeutic potential of ixekizumab
por: Hanley TL, et al.
Publicado: (2017)